Ignite Creation Date:
2025-12-24 @ 1:36 PM
Ignite Modification Date:
2026-05-22 @ 9:44 PM
Study NCT ID:
NCT02206295
Status:
COMPLETED
Last Update Posted:
2025-02-03
First Post:
2014-07-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg or as Single Tablet of 1600 μg
Sponsor:
Actelion
Organization: